Gametocyte surface protein P230 domain 1 (Pfs230D1) (Pfs230D1)

Gametocyte surface protein P230 (Pfs230) is a large, 363 kDa protein expressed on the surface of Plasmodium falciparum gametocytes and gametes [1, 12]. It belongs to the 6-Cys protein family and plays a vital role in the sexual stage of the parasite's life cycle, specifically in gamete fertilization and fusion within the mosquito midgut [1, 10]. Domain 1 (Pfs230D1) is the N-terminal-most 6-Cys domain and has been identified as the primary target for transmission-blocking vaccines (TBVs) due to its ability to elicit potent functional antibodies [3, 12, 13]. These antibodies interrupt the malaria transmission cycle by preventing the development of the parasite in the mosquito vector, often through complement-mediated lysis of gametes or steric hindrance of essential protein-protein interactions [2, 3, 16]. Pfs230D1-based vaccines, such as Pfs230D1-EPA, are currently in clinical trials and represent a key component of global malaria elimination and eradication efforts [3, 12]. The protein is anchored to the gamete membrane through interactions with Pfs48/45, forming a complex that is essential for establishing mosquito infection [12, 16]. Targeting this domain aims to achieve herd immunity by reducing the infectious reservoir in human populations [3, 4]. Challenges in vaccine development include the requirement for proper folding of its cysteine-rich structure and the need for adjuvants to enhance the durability of the immune response [2, 5, 12].

Other names

Pfs230PF230S230PF3D7_0209000Gametocyte surface protein P230Pfs230D1M

Induction of transmission-blocking antibodies that inhibit parasite development in the mosquito midgut through complement-mediated lysis of gametes and steric hindrance of gamete fusion.